Humboldt Fund overview
Humboldt Fund contact information
Offices
477 Madison Ave, 6th Floor, New York, 10022, United StatesContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Mr. Benjamin Quiroga | Job titleGeneral Partner | LocationNew York, United States | Email  ------ |
| Mr. Sebastian Bernales | Job titleGeneral Partner | LocationNew York, United States | Email --------- |
| Mr. Francisco Dopazo | Job titleGeneral Partner | LocationNew York, United States | Email ------- |
Humboldt Fund funds managed
Closed funds: 1
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ---------- | Close date- | Strategy ------ | |
Stories that mention Humboldt Fund
Endpoint Health fetches $52m Series A
Endpoint Health Inc, a precision-firstTM therapeutics company, has secured $52 million in Series A funding.
Cellino Biotech rallies $80m Series A
Cellino Biotech Inc., an autonomous cell therapy manufacturing company, has raised $80 million in Series A financing.
Debut Biotech attracts $22.6m Series A
Debut Biotech, a biomanufacturing platform harnessing cell-free enzymes, has raised $22.6 million in Series A financing.
Cellino rakes in $16m seed
Cellino, a personalized regenerative medicine company, has raised $16 million in seed funding.
MycoWorks garners $45m Series B
MycoWorks, a provider of luxury fashion and footwear brands, has raised $45 million in Series B financing, according to a blog post.
Metagenomi grabs $65m Series A
Metagenomi, a next-generation gene editing company, has secured $65 million in Series A financing.
Finch Therapeutics rallies $90m Series D
Somerville, Massachusetts-based Finch Therapeutics Group Inc, a clinical-stage microbiome drug development company, has secured $90 million in Series D financing.